loadpatents
name:-0.047437191009521
name:-0.022775173187256
name:-0.010066986083984
HUNG; Mien-Chie Patent Filings

HUNG; Mien-Chie

Patent Applications and Registrations

Patent applications and USPTO patent grants for HUNG; Mien-Chie.The latest application filed is for "combinatorial therapy targeting parp1 and rtk".

Company Profile
9.22.37
  • HUNG; Mien-Chie - Houston TX
  • Hung; Mien-chie - Taichung City TW
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Combinatorial Therapy Targeting Parp1 And Rtk
App 20220305015 - HUNG; Mien-Chie ;   et al.
2022-09-29
Detection of arginine methylation of EGFR for prediction of resistance to therapy
Grant 11,452,775 - Hung , et al. September 27, 2
2022-09-27
Antibodies Specific To Glycosylated Pd-l1 And Methods Of Use Thereof
App 20220276252 - YOO; Stephen S. ;   et al.
2022-09-01
Antibodies Specific To Glycosylated Pd-l1 And Methods Of Use Thereof
App 20220155307 - YOO; Stephen S. ;   et al.
2022-05-19
Use Of Disulfiram For Treating Infection Of SARS-COV-2
App 20210386695 - Tsai; Chang-Hai ;   et al.
2021-12-16
Use Of Tafenoquine, Boceprevir Or Narlaprevir For Treating Infection Of SARS-COV-2 And Medical Composition Thereof
App 20210330661 - Hung; Mien-Chie ;   et al.
2021-10-28
Detection Of Immune Checkpoint Molecules By Deglycosylation
App 20210156866 - LEE; Heng-Huan ;   et al.
2021-05-27
Antibodies Specific To Glycosylated Pd-1 And Methods Of Use Thereof
App 20210139588 - YOO; Stephen S. ;   et al.
2021-05-13
Antibodies specific to glycosylated PD-1 and methods of use thereof
Grant 10,858,432 - Yoo , et al. December 8, 2
2020-12-08
Antibodies specific to glycosylated PD-L1 and methods of use thereof
Grant 10,836,827 - Yoo , et al. November 17, 2
2020-11-17
Detection Of Arginine Methylation Of Egfr For Prediction Of Resistance To Therapy
App 20200093926 - HUNG; Mien-Chie ;   et al.
2020-03-26
Detection of arginine methylation of EGFR for prediction of resistance to therapy
Grant 10,537,635 - Hung , et al. Ja
2020-01-21
Flow Proteometric Methods For Digital Quantification And Binding Analysis
App 20190369106 - HUNG; Mien-Chie ;   et al.
2019-12-05
Prediction of response to PARP inhibitors and combinational therapy targeting C-MET and PARP1
Grant 10,451,610 - Hung , et al. Oc
2019-10-22
Methods Of Cancer Treatment And Therapy Using A Combination Of Anitbodies That Bind Glycosylated Pd-l1
App 20190218297 - YOO; Stephen S. ;   et al.
2019-07-18
Methods For Selecting Antibodies That Specifically Bind Glycosylated Immune Checkpoint Proteins
App 20190105403 - YOO; Stephen S. ;   et al.
2019-04-11
Dual Function Antibodies Specific To Glycosylated Pd-l1 And Methods Of Use Thereof
App 20190083644 - YOO; Stephen S. ;   et al.
2019-03-21
Antibodies Specific To Glycosylated Pd-1 And Methods Of Use Thereof
App 20190077866 - YOO; Stephen S. ;   et al.
2019-03-14
Antibodies Specific To Glycosylated Pd-l1 And Methods Of Use Thereof
App 20180118830 - YOO; Stephen S. ;   et al.
2018-05-03
Prediction Of Response To Parp Inhibitors And Combinational Therapy Targeting C-met And Parp1
App 20170219565 - HUNG; Mien-Chie ;   et al.
2017-08-03
Personalized medicine for the prediction of therapy targeting the hedgehog pathway
Grant 9,655,909 - Hung , et al. May 23, 2
2017-05-23
Detection Of Arginine Methylation Of Egfr For Prediction Of Resistance To Therapy
App 20160279240 - HUNG; Mien-Chie ;   et al.
2016-09-29
Personalized Medicine For The Prediction Of Therapy Targeting The Hedgehog Pathway
App 20150017651 - Hung; Mien-Chie ;   et al.
2015-01-15
Methods for detecting molecule-molecule interactions with a single detection channel
Grant 8,586,316 - Kameoka , et al. November 19, 2
2013-11-19
Antitumor effect of mutant Bik
Grant 8,304,526 - Hung , et al. November 6, 2
2012-11-06
Methods For Detecting Molecule-molecule Interactions With A Single Detection Channel
App 20120070846 - Kameoka; Jun ;   et al.
2012-03-22
Targeting proteins to deliver therapeutic or diagnostic reagents
Grant 7,906,628 - Hung , et al. March 15, 2
2011-03-15
Targeting proteins to deliver therapeutic or diagnostic reagents
Grant 7,893,033 - Hung , et al. February 22, 2
2011-02-22
Antitumor Effect Of Mutant Bik
App 20110020431 - Hung; Mien-Chie ;   et al.
2011-01-27
Cancer specific promoters
Grant 7,816,131 - Hung , et al. October 19, 2
2010-10-19
Cancer specific promoters
Grant 7,723,104 - Hung , et al. May 25, 2
2010-05-25
14-3-3 Zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer type
Grant 7,709,205 - Yu , et al. May 4, 2
2010-05-04
Cancer-specific Promoters
App 20090192101 - Hung; Mien-Chie ;   et al.
2009-07-30
Antitumor Effect Of Mutant Bik
App 20090075885 - Hung; Mien-Chie ;   et al.
2009-03-19
14-3-3 Zeta Over-expression As A Poor Prognosis Factor, And A Therapeutic Target In Multiple Cancer Type
App 20080318231 - YU; DIHUA ;   et al.
2008-12-25
Cancer Specific Promoters
App 20080286860 - Hung; Mien-Chie ;   et al.
2008-11-20
14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types
Grant 7,316,907 - Yu , et al. January 8, 2
2008-01-08
Targeting Proteins To Deliver Therapeutic Or Diagnostic Reagents
App 20070134206 - Hung; Mien-Chie ;   et al.
2007-06-14
Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells to chemotherapy
Grant 7,005,424 - Hung , et al. February 28, 2
2006-02-28
Cancer specific promoters
App 20050260643 - Hung, Mien-Chie ;   et al.
2005-11-24
IFIX, a novel HIN-200 protein, for cancer therapy
App 20050220781 - Yan, Duen-Hwa ;   et al.
2005-10-06
14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types
App 20050148532 - Yu, Dihua ;   et al.
2005-07-07
Antitumor effect of mutant Bik
App 20050118154 - Hung, Mien-Chie ;   et al.
2005-06-02
Predicting survival of patients with squamous cell carcinoma
Grant 6,852,483 - Hung , et al. February 8, 2
2005-02-08
Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy
App 20040053863 - Hung, Mien-Chie ;   et al.
2004-03-18
Mini-E1A gene and gene products
Grant 6,683,059 - Hung , et al. January 27, 2
2004-01-27
Targeting proteins to deliver therapeutic or diagnostic reagents
App 20040005684 - Hung, Mien-Chie ;   et al.
2004-01-08
Bipartite T-cell factor (Tcf)-responsive promoter
App 20030228285 - Hung, Mien-Chie ;   et al.
2003-12-11
Antitumor activity of Bok
App 20030139344 - Hung, Mien-Chie ;   et al.
2003-07-24
Anti-estrogen receptor agents for chemotherapy
App 20030125265 - Hung, Mien-Chie ;   et al.
2003-07-03
Mutant p21Cip1/WAF1 and cell growth control and cell growth control
App 20030113897 - Hung, Mien-Chie ;   et al.
2003-06-19
Beta-catenin is a strong and independent prognostic factor for cancer
App 20030064384 - Hung, Mien-Chie ;   et al.
2003-04-03
Methods and compositions for inhibiting EGF receptor activity
App 20030053995 - Hung, Mien-Chie ;   et al.
2003-03-20
Human PEA3 is a tumor suppressor for cancer cells
App 20030044392 - Xing, Xiangming ;   et al.
2003-03-06
Preparation and characterization of liposomal formulations of tumor necrosis factor
Grant 5,653,974 - Hung , et al. August 5, 1
1997-08-05
Methods for the suppression of neu mediated tumors by the adenoviral EIA gene
Grant 5,651,964 - Hung , et al. July 29, 1
1997-07-29
Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
Grant 5,643,567 - Hung , et al. July 1, 1
1997-07-01
Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
Grant 5,641,484 - Hung , et al. June 24, 1
1997-06-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed